Sigyn Therapeutics (SIGY) Share-based Compensation (2016 - 2025)
Sigyn Therapeutics' (SIGY) quarterly Share-based Compensation came in at $50000.0 in Q3 2025, up 33.33% year-over-year from $37500.0 in Q3 2024, and little changed quarter-over-quarter from $50000.0 in Q2 2025.
Powered by 
Analysis
Sigyn Therapeutics (SIGY) Share-based Compensation (2016 - 2025) Analysis & Trends
Sigyn Therapeutics has disclosed Share-based Compensation across 9 years of filings, most recently posting $50000.0 for Q3 2025.
- In Q3 2025, Share-based Compensation rose 33.33% year-over-year to $50000.0; the TTM figure through Sep 2025 stood at $187500.0 (down 13.02% YoY), while the FY2024 annual figure was $150000.0, down 30.41% from the prior year.
- Share-based Compensation came in at $50000.0 for Q3 2025 at Sigyn Therapeutics, roughly flat from $50000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $103058.0 in Q4 2023 to a low of $37500.0 in Q1 2023.
- Average Share-based Compensation over 4 years is $50977.2, with a median of $37600.0 recorded in 2021.
- Year-over-year, Share-based Compensation surged 403.55% in 2021 and plunged 63.61% in 2024.
- Over 4 years, Share-based Compensation stood at $37600.0 in 2021, then soared by 174.09% to $103058.0 in 2023, then plunged by 63.61% to $37500.0 in 2024, then surged by 33.33% to $50000.0 in 2025.
- Per Business Quant data, the three most recent Share-based Compensation figures were $50000.0 in Q3 2025, $50000.0 in Q2 2025, and $50000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | 50,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | 37,500.00 |
| Sep 30, 2024 | 37,500.00 |
| Jun 30, 2024 | 37,500.00 |
| Mar 31, 2024 | 37,500.00 |
| Dec 31, 2023 | 103,058.00 |
| Sep 30, 2023 | 37,500.00 |
| Jun 30, 2023 | 37,500.00 |
| Mar 31, 2023 | 37,500.00 |
| Dec 31, 2021 | 37,600.00 |
| Sep 30, 2021 | 47,000.00 |
| Jun 30, 2021 | 82,250.00 |
| Mar 31, 2021 | 82,250.00 |
| Jun 30, 2020 | 16,334.00 |
| Mar 31, 2020 | 26,916.00 |
| Dec 31, 2019 | 50.00 |
| Dec 31, 2018 | 82,310.00 |
| Sep 30, 2018 | 10.00 Mn |